1. Chrubasik S, Pittler MH, Roufogalis BD. Zingiberis rhizoma: a comprehensive review on the ginger effect and efficacy profiles. Phytomedicine. 2005; 12(9):684–701.
Article
2. National Institutes of Health (US). Dietary Supplement Label Database (DSLD) [Internet]. Bethesda (MA): National Institutes of Health;2013. 09. cited 2013 Sep 18. Available from:
http://www.dsld.nlm.nih.gov/dsld/.
3. Flake ZA, Scalley RD, Bailey AG. Practical selection of antiemetics. Am Fam Physician. 2004; 69(5):1169–1174.
4. Yamahara J, Rong HQ, Iwamoto M, Kobayashi G, Matsuda H, Fujimura H. Active components of ginger exhibiting anti-serotonergic action. Phytother Res. 1989; 3(2):70–71.
Article
5. Huang QR, Iwamoto M, Aoki S, Tanaka N, Tajima K, Yamahara J, Takaishi Y, Yoshida M, Tomimatsu T, Tamai Y. Anti-5-hydroxytryptamine3 effect of galanolactone, diterpenoid isolated from ginger. Chem Pharm Bull (Tokyo). 1991; 39(2):397–399.
Article
6. Korea Food & Drug Administration. Guidance for the Evaluation on the Functionality of Health Functional Food. Seoul: Korea Food & Drug Administration;2008. p. 30–32.
8. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) (IT). Scientific and technical guidance for the preparation and presentation of an application for authorisation of a health claim (revision 1). EFSA J [serial on the Internet]. 2011. cited 2013 Nov 17. 9(5):2170. [about 36 p.] Available from:
http://www.efsa.europa.eu/en/efsajournal/pub/2170.htm.
9. Jeong S, Kim JY, Paek JE, Kim J, Kwak JS, Kwon O. Systematic review of the effect of omega-3 fatty acids on improvement of blood flow while focused on evaluation of claims for health functional food. J Nutr Health. 2013; 46(3):226–238.
Article
10. Kim JY, Jeong S, Paek JE, Kim J, Kwak JS, Lee YJ, Kang TS, Kwon O. Systematic review of the effect of coenzyme Q10 on antioxidant capacity while focused on evaluation of claims for health functional food. J Nutr Health. 2013; 46(3):218–225.
Article
11. Sripramote M, Lekhyananda N. A randomized comparison of ginger and vitamin B6 in the treatment of nausea and vomiting of pregnancy. J Med Assoc Thai. 2003; 86(9):846–853.
12. Ensiyeh J, Sakineh MA. Comparing ginger and vitamin B6 for the treatment of nausea and vomiting in pregnancy: a randomised controlled trial. Midwifery. 2009; 25(6):649–653.
Article
13. Chittumma P, Kaewkiattikun K, Wiriyasiriwach B. Comparison of the effectiveness of ginger and vitamin B6 for treatment of nausea and vomiting in early pregnancy: a randomized doubleblind controlled trial. J Med Assoc Thai. 2007; 90(1):15–20.
14. Pongrojpaw D, Somprasit C, Chanthasenanont A. A randomized comparison of ginger and dimenhydrinate in the treatment of nausea and vomiting in pregnancy. J Med Assoc Thai. 2007; 90(9):1703–1709.
15. Vutyavanich T, Kraisarin T, Ruangsri R. Ginger for nausea and vomiting in pregnancy: randomized, double-masked, placebo-controlled trial. Obstet Gynecol. 2001; 97(4):577–582.
Article
16. Jackson EA. Is ginger root effective for decreasing the severity of nausea and vomiting in early pregnancy? J Fam Pract. 2001; 50(8):720.
17. Basirat Z, Moghadamnia A, Kashifard M, Sharifi-Razavi A. The effect of ginger biscuit on nausea and vomiting in early pregnancy. Acta Med Iran. 2009; 47(1):51–56.
18. Ozgoli G, Goli M, Simbar M. Effects of ginger capsules on pregnancy, nausea, and vomiting. J Altern Complement Med. 2009; 15(3):243–246.
Article
19. Fischer-Rasmussen W, Kjaer SK, Dahl C, Asping U. Ginger treatment of hyperemesis gravidarum. Eur J Obstet Gynecol Reprod Biol. 1991; 38(1):19–24.
Article
20. Weimer K, Schulte J, Maichle A, Muth ER, Scisco JL, Horing B, Enck P, Klosterhalfen S. Effects of ginger and expectations on symptoms of nausea in a balanced placebo design. PLoS One. 2012; 7(11):e49031.
Article
21. Grøntved A, Brask T, Kambskard J, Hentzer E. Ginger root against seasickness. A controlled trial on the open sea. Acta Otolaryngol. 1988; 105(1-2):45–49.
22. Schmid R, Schick T, Steffen R, Tschopp A, Wilk T. Comparison of seven commonly used agents for prophylaxis of seasickness. J Travel Med. 1994; 1(4):203–206.
Article
23. Regulations on statements made for dietary supplements concerning the effect of the product on the structure or function of the body. Food and Drug Administration, HHS. Final rule. Fed Regist. 2000; 65(4):1000–1050.
24. Korean Intellectual Property Office. Korean traditional knowledge portal [Internet]. Daejeon: Korean Intellectual Property Office;2013. cited 2013 Nov 20. Available from:
http://www.koreantk.com.